Prognostic Impact of 18F-FDG PET/CT in Patients With Aggressive B-Cell Lymphoma Treated With Anti-CD19 Chimeric Antigen Receptor T Cells
2021 · Clinical Nuclear Medicine · 78 citations
https://doi.org/10.1097/rlu.0000000000003756
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
46
Papers
565
Citations
12
h-index
14
i10-index
Anne Lazareth is an academic researcher from Communauté urbaine de Lyon. The author has contributed to research in topics: Multiple Myeloma Research and Treatments & CAR-T cell therapy research & Lymphoma Diagnosis and Treatment. The author has an h-index of 12, co-authored 40 publications.
https://doi.org/10.1097/rlu.0000000000003756
https://doi.org/10.1182/bloodadvances.2025017597
Click to start Chat